Pathstone Holdings LLC Sells 136 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Pathstone Holdings LLC lessened its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 1.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,061 shares of the company’s stock after selling 136 shares during the period. Pathstone Holdings LLC owned 0.07% of Addus HomeCare worth $1,738,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Addus HomeCare by 1.5% during the first quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock worth $131,910,000 after acquiring an additional 19,027 shares during the period. CANADA LIFE ASSURANCE Co increased its holdings in Addus HomeCare by 4.7% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 16,837 shares of the company’s stock worth $1,738,000 after purchasing an additional 761 shares during the period. Lazard Asset Management LLC raised its position in Addus HomeCare by 11.9% during the 1st quarter. Lazard Asset Management LLC now owns 5,128 shares of the company’s stock valued at $529,000 after purchasing an additional 547 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in shares of Addus HomeCare by 683.7% in the 1st quarter. Janus Henderson Group PLC now owns 55,188 shares of the company’s stock worth $5,703,000 after buying an additional 48,146 shares during the period. Finally, Hancock Whitney Corp grew its position in shares of Addus HomeCare by 5.4% during the 1st quarter. Hancock Whitney Corp now owns 5,102 shares of the company’s stock worth $527,000 after buying an additional 263 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. TD Cowen raised their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Oppenheimer raised their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Stephens boosted their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Insider Buying and Selling

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. This represents a 12.93 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,500 shares of company stock worth $1,668,265 in the last 90 days. 4.60% of the stock is owned by corporate insiders.

Addus HomeCare Stock Down 2.5 %

NASDAQ ADUS opened at $121.29 on Thursday. The firm has a market cap of $2.20 billion, a PE ratio of 28.47, a price-to-earnings-growth ratio of 2.15 and a beta of 1.04. The company has a 50 day moving average price of $127.91 and a 200 day moving average price of $123.51. Addus HomeCare Co. has a 52 week low of $85.43 and a 52 week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.03 EPS. On average, equities research analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.